Replacing an Open System Using Air with a Closed System Using Heliox.
Maximizing Uptake of Treatment into the Bloodstream by Introducing Heliox.
Smart Technology Leading to Better Results.
During severe acute asthma exacerbations, it has been found that albuterol nebulized with Heliox leads to a more significant improvement in spirometry when compared with albuterol nebulized with oxygen because the low-density gas improves albuterol deposition in the distal airways.
Inhalation of Heliox results in significantly lower turbulence, particularly in the more distal portions of the lung. The decreased turbulence results in an increased flow by up to 50% during Heliox inhalation.
Evidence continues to evolve that heliox can effectively reduce airway resistance and work of breathing in patients with severe airway obstruction and can improve delivery of aerosol by reducing turbulence and aerosol particle impact en route to the lungs.
BENEFITS OF HELIOX
Popular Mixtures are:
Helium – Oxygen 80/20
1.805 times less dense compared to pure oxygen.
Helium – Oxygen 70/30
1.586 times less dense compared to pure oxygen.
The initial thrust of PST’s product development will be a transportable desktop version of the PST Heliox inhaler for the CBD market. Pure Scientific Technologies believes the fundamental improvement in aerosol delivery of CBD with Heliox potentially offers strong near-term financial opportunity with minimal regulatory oversite.
Early design development knowledge will then be leveraged into new products for delivery of pharmaceuticals directly into the lungs for treatment of lung disease, and ultimately diseases affecting other body sites.
First product Helios to be released in the Holistic CBD market designed for use of CBD for those currently using CBD for chronic conditions use cases.